IDH1 and central nervous system cancer: Some of these aberrations are not unique to IDH-mutant gliomas, such as increased choline peak near 3.2 ppm, which sums contributions from multiple choline-containing metabolites, including free choline, phosphorylcholine, and glycerophosphorylcholine.